Sobre 7 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the complete record of transactions filed by Lewis William, Presidente y Director General. Director active across 4 companies, notably INSMED Inc. Cumulatively, 81 filings have been logged. Breakdown: 1 buy · 28 sells. Total volume traded: €8.6m. History available since 15 May 2021. The latest transaction was disclosed on 9 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
6259 títulos@ 30,46 US$50.0% de su flujoCommon StockSEC:0001402051-26-000020:0
25 de 81 declaraciones
About Lewis William
Lewis William is Chair and CEO of INSMED Inc and a director of NewAmsterdam Pharma Co N.V. He has made a total of 55 filings. In the most recent filings, he sold a total of 5,188,114 euros, with notable transactions including a sale of 1,317,183.65 euros on May 15, 2026, and another sale of the same amount on the same day. The first filings date back to February 3, 2016, and the most recent continue until June 26, 2026.